Search

everythinglearnresearchcommunity

for

Search:↓

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

Finasteride and minoxidil work best together for hair loss.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Bimatoprost helped eyelash growth in nearly half of the patients with a type of eyelash hair loss.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Rats had lasting erectile problems after stopping a certain medication.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Finasteride capsules with nanoparticles improve drug delivery, solubility, stability, and effectiveness.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

Silver nanoparticles made from jackfruit leaf extract are effective against bacteria and fungi.

Cedrol Nanoemulsion was found to be more effective at promoting hair growth than traditional treatments and had better bioavailability.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Integrating best practices for steroid users in Swiss primary care is feasible and beneficial, but doping laws need change.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.